Form D · Private Equity Fund
HCC-Cadence Investments, LLC
New York, NY · CIK 0002135857
Offering snapshot reported May 28, 2026 · SEC filing
- Reported sold
- $8.28M Offering amount: $8.28M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 8, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 28, 2026 | Initial | $8,280,000 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-585425
Source: Form D, filed May 28, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles N/A Boorady | Executive |
| N/A N/A Health Catalyst Capital Management, Llc | Promoter |
| Boris N/A Pevzner | Executive |
| Paula N/A Semelmacher | Executive |
| Garen N/A Throneberry | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
515 Madison Avenue Suite 2701
New York, NY, 10022
New York, NY, 10022